Covid-19: from structure to therapeutic targeting in studying approved drugs and local DNA vaccination.
Covid-19: from structure to therapeutic targeting in studying approved drugs and local DNA vaccination.
Clin Exp Pharmacol Physiol. 2020 Sep 25;:
Authors: Wang Z, Hong X, Wang H, Liu J, Liu JP
Abstract
The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented threat to global public health. The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infections in a global scale has affected more than 30.6 million people suffering the COVID-19, resulting in more than 955,000 deaths globally as of the 20 September 2020. The current lack of specific and effective therapies for the COVID-19, and the continuous spread of coronavirus SARS-CoV-2 across many parts of the world, represent one of the major challenges in controlling the disease severity, keeping to pose a huge threat to the global health.
PMID: 32976637 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Pharmacology and Physiology - Category: Drugs & Pharmacology Authors: Wang Z, Hong X, Wang H, Liu J, Liu JP Tags: Clin Exp Pharmacol Physiol Source Type: research
More News: Coronavirus | COVID-19 | Drugs & Pharmacology | International Medicine & Public Health | Pandemics | Physiology | Respiratory Medicine | SARS | Vaccines